http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105012350-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-145 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
| filingDate | 2015-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105012350-B |
| titleOfInvention | Probiotics clostridium butyricum bacterial strain |
| abstract | The invention belongs to life sciences, are related to application of the probiotics preparation in preparing treatment and preventing vascular dementia, and in particular to the new medicine use of clostridium butyricum treatment of vascular dementia.Vascular dementia is the brain tissue damage occurred on the basis of a variety of cranial vascular diseases, and then using cognition dysfunction as the syndrome of main clinical manifestation, the invention discloses one kind to have treatment of vascular dull-witted, and probiotics preparation includes drug, health products and drink, and does not find any toxic side effect.The present invention starts the new model for the treatment of of vascular dementia creatively using intestinal flora as therapy target, has not only mitigated disease symptoms but also has slowed down neural cell injury, has good economic results in society, is worthy of popularization. |
| priorityDate | 2015-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.